In March 2015 we issued a report summarising the work undertaken during the first year of the project. Our second report, for year 2 of Merlin is now available. You can access the year 2 report below. MERLIN Report Year 2
Author Archive for: merlin_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud merlin_admin contributed a whooping 55 entries.
Entries by merlin_admin
Dr. Madhu Gargesha of BioInVision presented a paper titled “MSC pre-treatments lead to better cell survival in mouse models of liver disease: A CryoViz Study” at the American Association of Immunologists (AAI) 2016 Conference in Seattle, Washington, USA, May 13-16 2016. The presentation was very well received and generated a lot of interest in the […]
Researchers from Merlin project partner Erasmus MC recently made a number of presentations at the Dutch Transplantation Society Meeting held on 9 and 10 March 2016 in Groningen. These included a poster presentation about the Merlin project entitled “Optimizing the immunogenicity and immunomodulatory properties of MSC “, (S.F.H. de Witte et al). For more details […]
MERLIN is developing stem cell-based therapies that specifically target the inflammatory components of liver disease. Our partners BioInVision have developed a cryo-imaging system for 3D, microscopic imaging – the CryoViz instrument. CryoViz enables you to do cellular and molecular imaging where you get colour anatomy and exactly-registered multi-spectral molecular fluorescence. Check out our video, which shows […]
The group of Prof. Antonella Viola from University of Padua has recently published a review titled “Mesenchymal stem cells: myths and reality” in “Swiss Medical Weekly”, the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology and the Swiss Society of Rheumatology. In this review, they identified what […]
MERLIN will be presented in a bespoke session at EASL to highlight EU initiatives. An abstract we submitted to EASL has also been accepted as a parallel session oral presentation. The EASL 2016 Annual Meeting will be held in Barcelona 13-17 April 2016. EASL – The Home of Hepatology – is Europe’s preeminent liver association […]
The MERLIN team met at the Radisson Blu Hotel, Birmingham 28 – 29 January 2016 to discuss the results of our pre-clinical work. We discussed preparations for the MERLIN clinical trial, including results from our MSC bio-distribution studies, pre-clinical experiments, and progress on the GMP manufacture of our stem cell therapy for PSC. We were joined by three […]
MERLIN coordinating partner University of Birmingham (UoB) is a centre of excellence for stem cell therapy and home to the MRC Centre of Immune Regulation. The University also has an unrivaled programme of human liver research, run through the Centre for Liver Research. Check out this video, where you can learn more about the UoB […]
MERLIN researchers participated in the EU-MSC2 meeting in Leiden on the 7th and 8th of September 2015 The two-day meeting brought together researchers from nine EU-funded projects pursuing MSC research. In addition to REDDSTAR, other projects represented at the meeting included ADIPOA-2, REDDSTAR, VISICORT, Stellar, RETHRIM, REACH, MERLIN,SCIENCE and NEPHSTROM. After a welcome from Henri Lenferink, Mayor […]
EuroStemCell recently came up with a new way to get the most out of a public event – they turned their fact sheets into an exhibition. From the content of the fact sheets with their quality, trustworthy and double-checked information, they created colourful posters about stem cells, stem cell research and diseases. And it worked! […]
- RT @LongerLifeOrg: Nonalcoholic fatty liver disease is the only liver disease with growing prevalence in the U.S. in the last 30 years. Epi… Time ago 26 Days via Twitter for iPhone
- RT @AutoImmuneLiver: Stay conmected with patient support groups @PSCSupportUK @PSCPartners to keep up with progress. Cure is a challenge bu… Time ago 134 Days via Twitter Web Client
- RT @nephstrom: JUST OUT! A new #OpenAccess @nephstrom publication in @FrontImmunol from our partners at @Istituto di Ricerche Farmacologich… Time ago 134 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.